See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2016_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 47,244,370 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 521,378 |
| 3 | remainder_Assets | 696,531 |
| 4 | LiabilitiesCurrent | 7,746,978 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 243,647 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,805,396 |
| 9 | ResearchAndDevelopmentExpense | 25,050,179 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 20,070,750 |
| 12 | remainder_NetIncome | 15,327 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,462,279 |
| 1 | Liabilities | 7,990,625 |
| 2 | Expenses | 32,855,575 |
| 3 | Revenues | 20,070,750 |
| 4 | StockholdersEquity | 40,471,654 |
| 5 | NetIncome | -12,769,498 |
| 6 | ComprehensiveNetIncome | -12,769,498 |
| 7 | BaseVar | 54,697,278 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.67 |
| 9 | EconomicCapitalRatio | 3.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
